Multicenter preclinical validation of BET inhibition for the treatment of pulmonary arterial hypertension, Am J Respir Crit Care Med, vol.200, pp.910-920, 2019. ,
First-in-human phase I study of the bromodomain and extraterminal motif inhibitor BAY 1238097: emerging pharmacokinetic/pharmacodynamic relationship and early termination due to unexpected toxicity, Eur J Cancer, vol.109, pp.103-110, 2019. ,
Drugging transcription in heart failure, J Physiol, 2019. ,
Bromodomain and extra-terminal protein mimic JQ1 decreases inflammation in human vascular endothelial cells: implications for pulmonary arterial hypertension, Respirology, vol.22, pp.157-164, 2017. ,
The BET bromodomain inhibitor I-BET-151 induces structural and functional alterations of the heart mitochondria in healthy male mice and rats, Int J Mol Sci, vol.20, p.1527, 2019. ,
URL : https://hal.archives-ouvertes.fr/inserm-02567799
Developmental regulation of mitochondrial apoptosis by c-Myc governs age-and tissue-specific sensitivity to cancer therapeutics, Cancer Cell, vol.31, pp.142-156, 2017. ,